Interviews

Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.

Srikala Sridhar, MD, discusses results from the phase 2 ALPACA study evaluating avelumab in patients with locally advanced or metastatic penile cancer who were unfit for or experienced disease progression after platinum-based chemotherapy.

Michele Reni, MD, discusses results from the phase 3 CASSANDRA trial which demonstrated that neoadjuvant PAXG significantly improved event-free survival compared to mFOLFIRNOX among patients with resectable or borderline resectable pancreatic...

Sarah Rutherford, MD, discusses recent updates in frontline treatment for patients with diffuse large B-cell lymphoma.

Erika Hamilton, MD, discusses results from the phase 3 VERITAC-2 study which revealed vepdegestrant yielded longer progression-free survival vs fulvestrant among patients with ER-positive, HER2-negative advanced breast cancer and an ESR1...

Sameera Kumar, MD, highlights the role radiation plays in the treatment of patients with stage 3 non-small cell lung cancer.

Juan Gimenez, MD, discusses the implications of a recent analysis of yttrium-90 (Y-90) glass microsphere radioembolization for interventional radiology.

Additional confirmatory tests for progressive disease are not needed to determine progression among patients with MM after 2 biomarkers have met the criteria of progression at the same time, according to a retrospective study.

In this video, a panel of experts discuss PIK3CA-mutant metastatic breast cancer, including an overview of the PI3 kinase pathway in cancer.

At the 2024 SGO Annual Meeting on Women’s Cancers, Bradley Corr, MD, discusses the results from a study evaluating rucaparib maintenance therapy for patients with metastatic or recurrent endometrial cancer.